医疗事务外包市场规模、份额、成长分析、按服务类型、按行业、按最终用户、按地区 - 行业预测，2025-2032 年

2023年医疗事务外包市场规模为19.2亿美元，从2024年的21.8亿美元成长到2032年的60.5亿美元，预测期（2025-2032）预计复合年增长率为13.6%。

由于传染性疾病和非传染性疾病盛行率的上升导致临床试验的增加，全球医疗事务外包市场正经历显着成长。临床活动的激增推动了对医疗设备和创新药物的需求，并增加了对医疗服务外包的需求。来自委外研发机构(CRO) 的经济高效、高品质的解决方案和严格的监管要求正在推动这一市场势头。透过加强虚拟科学交流和优先考虑科学交流，COVID-19 大流行预计将改变医疗事务专业人员的工作流程，并重新定义医疗事务的角色。此外，由于定价、严格法规和专利到期等挑战影响利润率，外包医疗业务越来越被视为优化业务和降低成本的策略倡议。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 案例研究
• 贸易分析

按服务类型分類的医疗事务外包市场规模

• 市场概况
• 医学写作和出版
  • 临床试验报告
  • 规范文件
  • 科学出版品
• 医疗监测
  • 安全监控
  • 有效性监控
• 医疗资讯
  • 询价回复
  • 医学文献综述
• 医药学术专员(MSL)
  • KOL (KOL) 参与度
  • 科学传播
• 监管业务
  • 监理意见书
  • 合规管理
• 其他的
  • 药物警戒
  • 培训和教育

医疗事务外包市场规模：依产业分类

• 市场概况
• 药品
• 生物技术
• 医疗设备

医疗事务外包市场规模：依最终用户分类

• 市场概况
• 小型企业
• 大公司

医事外包市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• ICON plc（Ireland）
• IQVIA Holdings Inc.（USA）
• The Medical Affairs Company（TMAC）（USA）
• Syneos Health, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• PAREXEL International Corporation（USA）
• PPD, Inc.（USA）
• Charles River Laboratories（USA）
• Covance Inc.（USA）
• Medpace Holdings, Inc.（USA）
• Pharm-Olam International（USA）
• Clinipace Worldwide（USA）
• PRA Health Sciences（USA）
• KCR SA（Poland）
• WuXi AppTec（China）
• SGS SA（Switzerland）
• Premier Research（USA）

结论和建议

Medical Affairs Outsourcing Market size was valued at USD 1.92 Billion in 2023 and is poised to grow from USD 2.18 Billion in 2024 to USD 6.05 Billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).

The global medical affairs outsourcing market is experiencing significant growth, driven by an increase in clinical trials attributed to the rising prevalence of both communicable and non-communicable diseases. This surge in clinical activity boosts demand for medical devices and innovative drugs, enhancing the need for outsourced medical services. Cost-effective, high-quality solutions from contract research organizations (CROs) and rigorous regulatory requirements add to this market's momentum. The COVID-19 pandemic has transformed medical affairs professionals' workflows, enhancing virtual scientific interactions and prioritizing scientific communication, which is expected to redefine medical affairs roles. Additionally, with pressures such as pricing challenges, strict regulations, and patent expirations affecting profit margins, outsourcing medical affairs functions is increasingly viewed as a strategic move to optimize operations and reduce costs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Affairs Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Affairs Outsourcing Market Segmental Analysis

Global Medical Affairs Outsourcing Market is segmented by service type, industry, end-user and region. Based on service type, the market is segmented into medical writing & publishing, medical monitoring, medical information, medical science liaisons (MSLS), regulatory affairs and others. Based on industry, the market is segmented into pharmaceuticals, biotechnology and medical devices. Based on end-user, the market is segmented into small & medium enterprises (SMEs) and large enterprises. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Medical Affairs Outsourcing Market

The Medical Affairs Outsourcing market is significantly driven by the escalating demand for real-world evidence in the healthcare sector, which is essential for validating product efficacy and safety. As pharmaceutical and medical device companies prioritize their core functions-research, development, manufacturing, and marketing-outsourcing medical affairs has become a strategic move. By collaborating with specialized providers, these companies can effectively generate, analyze, and communicate real-world data, thereby reinforcing the value propositions of their products. This approach not only allows them to utilize expert knowledge but also optimizes resource allocation and improves overall operational efficiency in an increasingly competitive landscape.

Restraints in the Medical Affairs Outsourcing Market

The Medical Affairs Outsourcing market faces several constraints, notably regarding quality control and compliance risks. Entrusting medical affairs functions to external vendors can pose challenges in maintaining consistent quality and complying with established internal standards. To effectively address these concerns, companies must implement strong governance and monitoring systems. Additionally, outsourcing can foster a dependency on outside providers for essential services, potentially diminishing a company's control over critical processes and timelines. This reliance may hinder operational efficiency and increase the risk of non-compliance, ultimately affecting the overall effectiveness of the medical affairs functions being outsourced.

Market Trends of the Medical Affairs Outsourcing Market

The Medical Affairs Outsourcing market is witnessing a significant upward trend as pharmaceutical and medical device companies leverage real-world evidence to substantiate the safety, efficacy, and value of their products. This shift towards evidence-based strategies is driving demand for specialized outsourcing providers adept at generating, analyzing, and interpreting real-world data. These providers are crucial in enhancing regulatory submissions and informing strategic decision-making, leading to a burgeoning market for outsourcing services in medical affairs. Companies are increasingly prioritizing partnerships that facilitate robust evidence generation, positioning medical affairs outsourcing as a vital component of their overall research and development efforts.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Trade Analysis

Global Medical Affairs Outsourcing Market Size by Service Type & CAGR (2025-2032)

• Market Overview
• Medical Writing & Publishing
  • Clinical Trial Reports
  • Regulatory Documents
  • Scientific Publications
• Medical Monitoring
  • Safety Monitoring
  • Efficacy Monitoring
• Medical Information
  • Inquiry Handling
  • Medical Literature Review
• Medical Science Liaisons (MSLs)
  • Key Opinion Leader (KOL) Engagement
  • Scientific Communication
• Regulatory Affairs
  • Regulatory Submissions
  • Compliance Management
• Others
  • Pharmacovigilance
  • Training & Education

Global Medical Affairs Outsourcing Market Size by Industry & CAGR (2025-2032)

• Market Overview
• Pharmaceuticals
• Biotechnology
• Medical Devices

Global Medical Affairs Outsourcing Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Small & Medium Enterprises (SMEs)
• Large Enterprises

Global Medical Affairs Outsourcing Market Size & CAGR (2025-2032)

• North America (Service Type, Industry, End-User)
  • US
  • Canada
• Europe (Service Type, Industry, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Industry, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Industry, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Industry, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Medical Affairs Company (TMAC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharm-Olam International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinipace Worldwide (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRA Health Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCR S.A. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations